Brii Biosciences launches long-acting COVID-19 neutralizing antibody therapy in China

Therapeutics |  News | 0 Comment | 11 Jul, 2022

Brii Biosciences, a multi-national company developing innovative therapies for diseases with significant unmet medi...Read more

Australian scientists provide insights into colon cancer prevention

Therapeutics |  News | 0 Comment | 06 Jul, 2022

Scientists in Australia have isolated five strains of gut bacteria that could pave the way for new inflammatory bowel di...Read more

“ATH434 has the potential to address the underlying pathology of Multiple System Atrophy”

Therapeutics |  Opinion | 2 Comment | 05 Jul, 2022

In conversation with BioSpectrum Asia, Dr David Stamler, Chief Executive Officer, Alterity Therapeutics reveals more abo...Read more

Singapore develops thermogel to prevent retinal scarring

Therapeutics |  News | 0 Comment | 05 Jul, 2022

Scientists from A*STAR’s Institute of Molecular and Cell Biology (IMCB) and Institute of Materials Research and En...Read more

Australia explores deadly spider venom treatment for heart attacks with $23M funding

Therapeutics |  News | 0 Comment | 04 Jul, 2022

A potentially life-saving treatment containing venom from one of the world’s deadliest spiders is one step closer ...Read more

First-ever gut microbiome banking service launches in Southeast Asia

Therapeutics |  News | 0 Comment | 22 Jun, 2022

Cordlife Group, a Singapore Exchange mainboard listed consumer healthcare company, and AMILI, have announced a strategic...Read more

Singapore enables doctors to optimise personalised chemotherapy dose

Therapeutics |  News | 0 Comment | 17 Jun, 2022

A team of researchers from National University of Singapore (NUS), in collaboration with clinicians from the Natio...Read more

Korea gives new hope to patients suffering from chronic shoulder pain

Therapeutics |  News | 0 Comment | 13 Jun, 2022

A research team at Pohang University of Science and Technology, South Korea has developed a complex tissue platform...Read more

Hong Kong opens Centre for Eye and Vision Research

Therapeutics |  News | 0 Comment | 13 Jun, 2022

At the forefront of the population’s health and aging imperative and with its mission of generating innovative tec...Read more

Australia’s mRNA projects receive funding boost

Therapeutics |  News | 0 Comment | 13 Jun, 2022

Two Monash University projects using mRNA delivery to improve treatments for people with muscular dystrophy or metabolic...Read more

Singapore uses nanotechnology to destroy, prevent relapse of solid tumour cancers

Therapeutics |  News | 0 Comment | 10 Jun, 2022

In a breakthrough development, a team of scientists led by Nasrat Muzayyin Chair Professor Chen Xiaoyuan from the Nation...Read more

Clinical trials indicate successful cancer remission through immunotherapy

Therapeutics |  News | 0 Comment | 09 Jun, 2022

Cancer tumors disappeared who have received an experimental immunotherapy drug called dostarlimab (brand name ...Read more

WHO recommends a new regimen for HIV and visceral leishmaniasis co-infection

Therapeutics |  News | 0 Comment | 09 Jun, 2022

The World Health Organization (WHO) has published new treatment recommendations for visceral leishmaniasis in patients c...Read more

Australia-US research revolutionises how chemotherapy is used for colon cancer patients

Therapeutics |  News | 0 Comment | 10 Jun, 2022

Australian-American researchers have co-designed a blood test that uses circulating tumour DNA (ctDNA) to precisely iden...Read more

Singapore organizations outline Genomics in developing drugs, vaccines, and precision medicine

Therapeutics |  Analysis | 2 Comment | 08 Jun, 2022

A new whitepaper, commissioned by Lenovo & Intel, led by IDC highlights key challenges and drivers transforming the ...Read more

Australia discovers new weapon against drug-resistant malaria

Therapeutics |  News | 0 Comment | 07 Jun, 2022

A new method to combat malaria which sees the disease turn against itself could offer an effective treatment for the hun...Read more

Booster shot key to protect against Omicron infection: Hong Kong study

Therapeutics |  News | 0 Comment | 03 Jun, 2022

The efficacy and effectiveness of individual vaccine products for COVID-19 and its variants of concern are well known. H...Read more

Boehringer Ingelheim partners with A*STAR in Singapore for targeted cancer therapies

Therapeutics |  News | 0 Comment | 03 Jun, 2022

German firm Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) in Singapore have announce...Read more